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diseases and are associated with devastating morbidity.
The basic, physiological and spontaneous reactions of the
organism to vascular occlusion are to develop adaptative
collateral circulation(s) outside the ischemic region, which
can potentially replace the feeding capacity of the larger
arteries. From the point of view of the interventionalist,
the intracranial anatomy, as well as the extreme mechano-
sensitivity of the brain arteries, leave few degrees of
freedom to surgical actions, in contrast to situations else-
where in the body. Moreover there are major differences
between the brain arteries and their constitutive vascular
cells of the brain with arteries lying outside the brain. The
cerebral vasculature is made of low-resistance vessels
containing neural crest-derived vascular cells opposing
high-resistance vessels made of mesoderm-derived vascular
smooth muscle cells in the peripheral arteries.
The paper by Wilma Schierling and colleagues1 is one
example of the recent attempts to develop new thera-
peutic options aimed at favoring the brain arteriogenesis by
acting upon the haemodynamic properties of cerebral
arteries by modifying one of the blood flow components,
i.e. the fluid-shear stress which previously has been shown
to be the pivotal trigger of cerebral arteriogenesis.2e4
Various experimental models have been used.1e4 The
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arteries, and follow-up is based on imaging and appropriate
molecular and haemodynamic investigations in the poste-
rior cerebral arteries after 7 days.
There is abundant literature, which addresses the molec-
ular machinery of neoangiogenesis and arteriogenesis,
focusing on a large variety of vascular cell growth factors. The
present paper is part of a programme by the same team to
investigate whether calcium-dependent signalling potent-
ially plays and important role in neovascularization and
arteriogenesis, whether or not associated with ischaemic
processes.3,4 The authors attempt to establish relationships
betweenmaximally-induced shear stress and theactivationof
vascular mechano-receptors; specifically, the transient
receptor potential cation channels (trp), as compared with
trp activation by drugs (e.g. phorbol ester and ruthenium red,
which are not available for human use).
The major finding of the present report is the identifi-
cation of the 4th member of the subfamily V of the
mechanosensitive transient receptor potential cation-
channel (Trpv4) as the pivotal fluid-shear stress-sensitive
actor of arteriogenesis. The pharmacological activation of
Trpv4 increases both m-RNA and protein-expression in brain
vessels and increased collateral growth to the same extent
as did maximum fluidshear stress-stimulation.
Although the present study raised numerous questions,
such as the identification of functional and downstream
consequences of the procedures there are basic innovative
findings. The study offers a prospect of a novel molecular
target for new therapeutic strategies. In addition, the
modality of altering brain hemodynamics in order tod by Elsevier Ltd. All rights reserved.
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potential interest is the finding that preventing rapid
normalization of fluidshear stress (as exampled using AV
shunts) furthers arteriogenesis in a non-pharmacological
manner.
These promising early results require assessment of
whether they can be translated into the clinical situation of
how to utilize either or both molecular and haemodynamics
therapeutic targets.
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